[go: up one dir, main page]

PT1025067E - Processo para a cristalizacao de compostos impedidos estereoquimicamente - Google Patents

Processo para a cristalizacao de compostos impedidos estereoquimicamente

Info

Publication number
PT1025067E
PT1025067E PT98945420T PT98945420T PT1025067E PT 1025067 E PT1025067 E PT 1025067E PT 98945420 T PT98945420 T PT 98945420T PT 98945420 T PT98945420 T PT 98945420T PT 1025067 E PT1025067 E PT 1025067E
Authority
PT
Portugal
Prior art keywords
stereo
crystallization
compounds
solution
impaired
Prior art date
Application number
PT98945420T
Other languages
English (en)
Inventor
Jan Cervenka
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of PT1025067E publication Critical patent/PT1025067E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00Purification; Separation; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Epoxy Compounds (AREA)
PT98945420T 1997-10-02 1998-10-02 Processo para a cristalizacao de compostos impedidos estereoquimicamente PT1025067E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720969.6A GB9720969D0 (en) 1997-10-02 1997-10-02 Process

Publications (1)

Publication Number Publication Date
PT1025067E true PT1025067E (pt) 2004-11-30

Family

ID=10819971

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98945420T PT1025067E (pt) 1997-10-02 1998-10-02 Processo para a cristalizacao de compostos impedidos estereoquimicamente

Country Status (14)

Country Link
US (1) US6646171B2 (pt)
EP (1) EP1025067B1 (pt)
JP (1) JP4509375B2 (pt)
CN (1) CN1129566C (pt)
AT (1) ATE273945T1 (pt)
AU (1) AU9274898A (pt)
CA (1) CA2305569A1 (pt)
CZ (1) CZ295010B6 (pt)
DE (1) DE69825772T2 (pt)
ES (1) ES2227875T3 (pt)
GB (1) GB9720969D0 (pt)
NO (1) NO323567B1 (pt)
PT (1) PT1025067E (pt)
WO (1) WO1999018054A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6957220B2 (en) 2000-11-07 2005-10-18 Research Investment Networks, Inc. System, method and article of manufacture for tracking and supporting the distribution of content electronically
US7191442B2 (en) 2000-10-30 2007-03-13 Research Investment Network, Inc. BCA writer serialization management
ITMI20010773A1 (it) * 2001-04-11 2002-10-11 Chemi Spa Processo per la produzione di ioexolo ad elevata purezza
NO20043305D0 (no) 2004-08-09 2004-08-09 Amersham Health As Preparation of lodixanol
NO338295B1 (no) * 2004-08-09 2016-08-08 Ge Healthcare As Fremstilling av iodixanol.
NO342021B1 (no) * 2005-07-29 2018-03-12 Ge Healthcare As Kontinuerlig krystalliseringsprosess
NO20053687D0 (no) * 2005-07-29 2005-07-29 Amersham Health As Crystallisation Process.
NO20053676D0 (no) * 2005-07-29 2005-07-29 Amersham Health As Crystallisation Process
NO20055643D0 (no) * 2005-11-29 2005-11-29 Amersham Health As Preparation of lodixanol
EP1960348A1 (de) * 2005-12-05 2008-08-27 Bayer Schering Pharma Aktiengesellschaft Verfahren zur rückgewinnung von für pharmazeutische zwecke geeignetem iopromid aus mutterlaugen
DE102005059191B4 (de) * 2005-12-05 2008-02-07 Bayer Schering Pharma Ag Verfahren zur Rückgewinnung von für pharmazeutische Zwecke geeignetem Iopromid aus Mutterlaugen
US7723544B2 (en) * 2005-12-08 2010-05-25 Bayer Schering Pharma Ag Process for recovery of iopromide, suitable for pharmaceutical purposes, from mother liquors
EP1966110B1 (en) 2005-12-19 2013-04-24 Ge Healthcare As Purification process of iodixanol
CN101293855B (zh) * 2007-04-27 2012-08-29 上海冠杰生物医药科技有限公司 一种碘克沙醇的纯化方法
KR100976097B1 (ko) 2008-12-05 2010-08-16 주식회사 대웅제약 이오프로마이드의 z 이성체를 선택적으로 결정화하는 방법
US7999135B2 (en) 2009-07-21 2011-08-16 Ge Healthcare As Crystallization of iodixanol using ultrasound
US8962886B2 (en) * 2009-07-21 2015-02-24 Ge Healthcare As Synthesis of iodixanol in methanol
US7754918B1 (en) 2009-07-21 2010-07-13 Ge Healthcare As Crystallization of iodixanol in isopropanol and methanol
US8969619B2 (en) 2009-07-21 2015-03-03 Ge Healthcare As Synthesis of iodixanol in propyleneglycol
US8962887B2 (en) * 2009-07-21 2015-02-24 Ge Healthcare As Synthesis of iodixanol in 1-methoxy-2-propanol and water or methanol
US7999134B2 (en) 2009-07-21 2011-08-16 Ge Healthcare As Crystallization of iodixanol using milling
PT2504298T (pt) * 2009-11-26 2016-12-29 Imax Diagnostic Imaging Holding Ltd Preparação e purificação de iodoxanol
CN102079716B (zh) * 2009-11-26 2014-03-05 浙江台州海神制药有限公司 碘克沙醇的制备与纯化
CN102875411A (zh) * 2012-10-30 2013-01-16 广州牌牌生物科技有限公司 一种用大孔树脂分离纯化碘克沙醇注射剂原料的方法
CN111777525B (zh) * 2019-04-04 2021-08-27 成都西岭源药业有限公司 一种碘克沙醇的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
ATE20733T1 (de) * 1982-11-08 1986-08-15 Nyegaard & Co As Roentgenkontrastmittel.
IL110391A (en) * 1993-07-30 1998-12-06 Zambon Spa Process for the crystallization of iopamidol
DE4425340A1 (de) * 1994-07-18 1994-12-01 Ciba Geigy Ag Sterisch gehinderte Amine in neuen kristallinen und amorphen Modifikationen
PT101720A (pt) * 1995-06-08 1997-01-31 Hovione Sociedade Quimica S A Processo para a purificacao e cristalizacao de iopamidol

Also Published As

Publication number Publication date
US20020072639A1 (en) 2002-06-13
AU9274898A (en) 1999-04-27
ES2227875T3 (es) 2005-04-01
CZ20001169A3 (cs) 2000-09-13
GB9720969D0 (en) 1997-12-03
EP1025067B1 (en) 2004-08-18
NO323567B1 (no) 2007-06-11
JP4509375B2 (ja) 2010-07-21
NO20001470D0 (no) 2000-03-22
EP1025067A1 (en) 2000-08-09
CN1129566C (zh) 2003-12-03
CN1273574A (zh) 2000-11-15
CA2305569A1 (en) 1999-04-15
US6646171B2 (en) 2003-11-11
ATE273945T1 (de) 2004-09-15
CZ295010B6 (cs) 2005-05-18
JP2001519320A (ja) 2001-10-23
DE69825772D1 (de) 2004-09-23
NO20001470L (no) 2000-03-22
WO1999018054A1 (en) 1999-04-15
DE69825772T2 (de) 2005-08-25

Similar Documents

Publication Publication Date Title
PT1025067E (pt) Processo para a cristalizacao de compostos impedidos estereoquimicamente
FI952065A0 (fi) Foerfarande foer tillvaratagande av en kristalliserbar organisk foerening
BR9607438A (pt) Processo de recuperação de um composto orgânico de soluções
EA199900720A1 (ru) Способ кристаллизации ингибитора обратной транскриптазы с применением противорастворителя
BR8804985A (pt) Processo para recuperar trimetoxissilano a partir de uma mistura de trimetoxissilano e metanol,mistura esta capaz de formar um azeotropo
BR9003011A (pt) Processo para purificacao de triptofano
BR8707712A (pt) Processo para hidrogenacao de um composto organico insaturado
ATE187168T1 (de) Verfahren zur herstellung von 1-substituierten 2- cyanoimidazolen
BR9809687A (pt) Processo novo
EE04345B1 (et) Simvastatiini ja selle derivaatide valmistamise protsess
KR910002865A (ko) 피라노벤즈옥사디아졸 화합물 및 그 광학적 분할방법
BR9206218A (pt) Processo de aplicar cristais de peneira molecular a um suporte, catalisador, e, membrana
ES2196783T3 (es) Nuevo procedimiento de preparacion de la fexofenadina.
KR950032042A (ko) 비스페놀의 정제 방법
DE60036369D1 (de) Emulsionskristallisation mit rückführung
KR840004120A (ko) 아즈렌 유도체의 안정화 아즈렌 유도체의 안정화방법
BR8700515A (pt) Processo para separar compostos organicos oxigenados
ES2130755T3 (es) Procedimiento para la eliminacion de alcoxidos de titanio o de vanadio de mezclas liquidas de hidrocarburos.
ATE178051T1 (de) Verfahren zur herstellung einer physikalisch stabilen, kristallinen gamma-modifikation von para-aminobenzolsulfonamid
DE59603757D1 (de) Verfahren zur Herstellung von kristallinem O-Isopropylisoharnstoff-hydrochlorid
WO1997029082A1 (en) Process for producing optically active cyanohydrins
ES2092191T3 (es) Metodo para purificar derivados nucleosidos.
KR930000494A (ko) 2-(2-아미노티아졸-4-일)-2-(Syn)- 메톡시아미노아세트산의 정제방법
RO113039B1 (ro) Procedeu de obţinere a 1-(4-metoxibenzoil)-2-pirolidinonei
IT8125720A0 (it) Processo per la produzione dicomposti organici contenenti eteroatomi ossigenati.